
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE4A4889B77E231B4A4800086929FF.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="springeropen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331795/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Neurology">
<meta name="citation_title" content="Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis">
<meta name="citation_author" content="Nevin John">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author_institution" content="Department of Neurology, Monash Health, Melbourne, VIC Australia">
<meta name="citation_author" content="Andy Lim">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author_institution" content="Department of Neurology, Monash Health, Melbourne, VIC Australia">
<meta name="citation_author" content="Shevita Ram Sunthar">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author" content="Leon Zhang">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author" content="Joan Cheng">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author" content="Julie Boktor">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author" content="Victor Chong">
<meta name="citation_author_institution" content="Department of Neurology, Monash Health, Melbourne, VIC Australia">
<meta name="citation_author" content="Henry Ma">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author_institution" content="Department of Neurology, Monash Health, Melbourne, VIC Australia">
<meta name="citation_author" content="Thanh G Phan">
<meta name="citation_author_institution" content="Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia">
<meta name="citation_author_institution" content="Department of Neurology, Monash Health, Melbourne, VIC Australia">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="272">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="563">
<meta name="citation_doi" content="10.1007/s00415-025-13279-7">
<meta name="citation_pmid" content="40775082">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331795/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331795/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331795/pdf/415_2025_Article_13279.pdf">
<meta name="description" content="There are numerous immunotherapies that are effective in preventing relapses in neuromyelitis optica spectrum disorder (NMO-SD). With head-to-head clinical trials between immunotherapies lacking, Bayesian network meta-analysis can be used to compare ...">
<meta name="og:title" content="Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="There are numerous immunotherapies that are effective in preventing relapses in neuromyelitis optica spectrum disorder (NMO-SD). With head-to-head clinical trials between immunotherapies lacking, Bayesian network meta-analysis can be used to compare ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331795/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12331795">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s00415-025-13279-7"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/415_2025_Article_13279.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12331795%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12331795/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12331795/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331795/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-springeropen.png" alt="Springer logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Springer" title="Link to Springer" shape="default" href="https://doi.org/10.1007/s00415-025-13279-7" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Neurol</button></div>. 2025 Aug 8;272(9):563. doi: <a href="https://doi.org/10.1007/s00415-025-13279-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s00415-025-13279-7</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Neurol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Neurol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Neurol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Neurol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22John%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Nevin John</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Nevin John</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">
<sup>2</sup>Department of Neurology, Monash Health, Melbourne, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22John%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nevin John</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lim%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Andy Lim</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Andy Lim</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">
<sup>2</sup>Department of Neurology, Monash Health, Melbourne, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lim%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andy Lim</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sunthar%20SR%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Shevita Ram Sunthar</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Shevita Ram Sunthar</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sunthar%20SR%22%5BAuthor%5D" class="usa-link"><span class="name western">Shevita Ram Sunthar</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Leon Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Leon Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Leon Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Joan Cheng</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Joan Cheng</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joan Cheng</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boktor%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Julie Boktor</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Julie Boktor</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boktor%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julie Boktor</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chong%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Victor Chong</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Victor Chong</span></h3>
<div class="p">
<sup>2</sup>Department of Neurology, Monash Health, Melbourne, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chong%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Victor Chong</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Henry Ma</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Henry Ma</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">
<sup>2</sup>Department of Neurology, Monash Health, Melbourne, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Henry Ma</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Phan%20TG%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Thanh G Phan</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Thanh G Phan</span></h3>
<div class="p">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div class="p">
<sup>2</sup>Department of Neurology, Monash Health, Melbourne, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Phan%20TG%22%5BAuthor%5D" class="usa-link"><span class="name western">Thanh G Phan</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Medicine, School of Clinical Sciences, Monash University, 246 Clayton Road, Clayton, VIC Australia </div>
<div id="Aff2">
<sup>2</sup>Department of Neurology, Monash Health, Melbourne, VIC Australia </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 22; Revised 2025 Jul 14; Accepted 2025 Jul 16; Issue date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12331795  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40775082/" class="usa-link">40775082</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">There are numerous immunotherapies that are effective in preventing relapses in neuromyelitis optica spectrum disorder (NMO-SD). With head-to-head clinical trials between immunotherapies lacking, Bayesian network meta-analysis can be used to compare treatment interventions. Previous network meta-analyses have compared monoclonal antibodies but either not included newer complement inhibitors or earlier immunotherapies such as rituximab or tocilizumab.</p></section><section id="sec2"><h3 class="pmc_sec_title">Objective</h3>
<p id="Par2">To compare immunosuppressive treatments used in relapse prevention in NMO-SD.</p></section><section id="sec3"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par3">PubMed, EMBASE and Scopus were searched for randomised controlled trials until 20th September, 2024. Search terms strategy included <em>neuromyelitis optica, antibody</em> and <em>relapse</em>. Randomised controlled trials testing immunotherapies used in relapse reduction in NMO-SD were included. Of 550 studies screened, 8 clinical trials initially met inclusion criteria. The study was performed according to PRISMA guidelines by multiple observers. Bayesian fixed-effect network meta-analysis was conducted. The primary outcome was time to relapse. The secondary outcome was annualised relapse rate. Sensitivity analysis was undertaken in seropositive patients. Treatments were ranked using a probability measure called surface under the cumulative rank curve (SUCRA).</p></section><section id="sec4"><h3 class="pmc_sec_title">Results</h3>
<p id="Par4">Eight studies were included that contained a total 851 patients [716 (84%) seropositive]. There were six treatment interventions—ravulizumab, eculizumab, tocilizumab, rituximab, inebilizumab, satralizumab and the control arm (placebo/azathioprine). Ravulizumab was the ideal treatment (HR 0.00 (95%CrI 0.00–0.03), SUCRA 0.99) with a 98% probability of being the superior treatment in increasing time to relapse in NMO-SD. This was supported by secondary analysis of annualised relapse rate and the sensitivity analysis in seropositive patients.</p></section><section id="sec5"><h3 class="pmc_sec_title">Discussion</h3>
<p id="Par5">These findings suggest that ravulizumab had the highest probability of being the most superior treatment in decreasing relapse risk in NMO-SD.</p></section><section id="sec6"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s00415-025-13279-7.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Neuromyelitis optica spectrum disorder, Demyelinating disorders</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par6">Neuromyelitis optica spectrum disorder (NMO-SD) is a rare relapsing autoimmune disorder affecting the central nervous system encompassed by complement mediated astrocytopathy and inflammatory demyelination directed towards aquaporin water channels [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. NMO-SD can be seropositive (80%) with the presence of pathogenic antibodies against aquaporin-4 water channels; or seronegative (20%) [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Eighty to ninety percent have relapsing disease characterised by the clinical attacks causing several typical clinical syndromes—optic neuritis, brainstem and area postrema syndromes, hemispheric involvement, narcolepsy and longitudinally extensive transverse myelitis with disability directly related to relapses [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>].</p>
<p id="Par7">The long-term prevention of relapses is achieved through immune suppression. Previously, agents such as azathioprine, mycophenolate mofetil and rituximab, were used but more recently there have been several positive randomised controlled trials using monoclonal antibodies with differing mechanisms demonstrating significant efficacy in decreasing relapse risk. These include B cell depleting agents (inebilizumab, rituximab) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>], interleukin-6 drugs (satralizumab, tocilizumab) [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]; and complement inhibitors (ravulizumab, eculizumab) [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. These immunosuppressive agents reduce relapse risk by 60–90% compared to placebo (or active comparator azathioprine) [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. However, it is not clear whether one treatment is superior to another as there no head to head randomised controlled trials of monoclonal antibodies; and no ranking of immunosuppressive treatments is available. Cost and feasibility issues mean that head-to-head or multi-arm trials clinical trials are unlikely to be completed. Bayesian network meta-analysis (NMA) can be used to investigate the comparative effectiveness of multiple treatments that have not been compared directly using a network-based approach. There have been several recent network meta-analyses in NMO-SD but these have compared recently approved mono-clonal antibodies and did not include older monoclonal antibodies (rituximab, tociliuzmab) [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>], or did not include the most recently approved immunotherapy ravulizumab and used a frequentist approach [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. We use Bayesian network meta-analysis to compare all available immunosuppressive treatments for NMO-SD.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Eligibility criteria</h3>
<p id="Par8">This meta-analysis conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-Analyses of Health Care Interventions [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. We included clinical trials matching the following criteria: (1) participants: adult patients (≥ 18 years) diagnosed with NMOSD according to the Neuromyelitis Optica Diagnostic criteria [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>], (2) intervention: the monoclonal antibodies ravulizumab, rituximab, eculizumab, inebilizumab, satralizumab, and tocilizumab, the immunosuppressants AZA, MMF, cyclophosphamide, tacrolimus. The comparator was placebo or an active comparator (3) outcomes: time to relapse, annualized rate of relapse (ARR), defined as the number of relapses divided by the time in years, the number of patients who experienced relapse (4) study type: Randomised controlled trials. We excluded studies matching at least one of the following criteria: (1) study type: conference abstracts, case reports, review articles, and noncomparative studies, retrospective or prospective studies; (2) studies with incomplete or unreported data; (3) studies not written in English; (4) studies specifically considering patients with the myelin oligodendrocyte glycoprotein autoimmune disease (MOGAD).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Information sources</h3>
<p id="Par9">Two study authors (SR, LZ) independently searched MEDLINE, EMBASE, SCOPUS, clinicaltrials.gov and reference lists of relevant papers for clinical trials published up to September 20, 2024. Search terms included <em>neuromyelitis optica</em>, <em>antibody, relapse</em>. Only full published papers in English were considered. Reference lists of relevant articles and from experts in the field were involved in identifying relevant studies. Studies were managed through Covidence systematic review software [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Articles were included by consensus of the authors with any disagreements resolved by a third independent adjudicator.</p>
<p id="Par10">Data included trial name, author, cohort start and end years, publication year, baseline EDSS, cohort size, seropositivity, number of events, number of events in seropositive groups, hazard ratios. The geometry of the network was described by a network diagram. Assessment of risk of bias was performed using the Cochrane Risk of Bias tool for randomized trials and completed independently by three study authors (JC, JB, VC) [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Effect measures</h3>
<p id="Par11">Time to first relapse was the primary outcome measure. Secondary outcome measures were annualised relapse rate (ARR) which was the other outcome measure common to randomised clinical trials in NMO-SD. Relative treatments were expressed as hazard ratios with 95% confidence intervals. For ARR, the NMA was performed on the basis of the number of events over the total follow-up time with treatment exposure using a binomial regression model. Relative treatment effects were expressed as rate ratios (RRs) and 95% credibility intervals. A sub-group analysis was undertaken in those with seropositive NMO. As an additional analysis requested by reviewers, we compared treatments based on infection rates. We recorded number of patients with infections in each treatment group. This was also recorded for serious infections. Treatment rankings were estimated with surface under the cumulative ranking curve (SUCRA) value, which is the probability that a treatment has of being the best option [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The SUCRA is a summary measure of how likely each treatment is to be superior when compared with all other treatments in a network. Each treatment is given a probability of being ranked at each position, then the area under the curve of these cumulative probabilities is calculated as the SUCRA to give a summary measure of the full ranking distribution.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par12">We performed Bayesian NMA using R statistical software version 4.3.1 with the BUGSnet (Bayesian Inference Using Gibbs Sampling to Conduct an NMA) and JAGS (Just Another Gibbs Sampler) packages (R Project for Statistical Computing) [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Bayesian network meta-analysis is a method that allows comparison of multiple treatments, even if these treatments have not been directly compared with each other, by connecting head-to-head trials together into a network and making direct and indirect comparisons. From this, both probability distributions for each pair of comparisons and treatment rankings can be calculated. The BUGSnet library is recommended for NMA because it provides the necessary output required by various societies including the International Society of Pharmacoeconomics and Outcomes–Academy of Managed Care Pharmacy–National Pharmaceutical Council [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. NMA was used because of the ability to rank treatments using the SUCRA value [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Assessment of inconsistency, which refers to the agreement between indirect and direct evidence within a network, was tested using the inconsistency model [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>], as recommended by the National Institute for Health and Clinical Excellence Decision Support Unit [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>], Statistical significance was considered a two-sided <em>P</em> &lt; 0.05.</p></section></section><section id="Sec7"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec8"><h3 class="pmc_sec_title">Study characteristics</h3>
<p id="Par13">Eight clinical trials were identified that met inclusion criteria with the majority of studies excluded for not being randomised controlled trials (Fig. <a href="#Fig1" class="usa-link">1</a>). The 8 clinical trials included 851 participants of which 716 (84%) were seropositive and 135 (16%) were seronegative. Five randomised controlled trials included both seropositive and seronegative patients, whilst 3 included only seropositive NMO-SD. Six randomised controlled trials used placebo as the comparator whilst 2 used an active comparator, azathioprine [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. All used the same outcome measure using a time to event analysis using the primary outcome measure of time to relapse except for the study of rituximab vs azathioprine by Nikoo et al. which used annualised relapse rate as the primary outcome measure. The study characteristics are shown in Table <a href="#Tab1" class="usa-link">1</a>. The network diagram is shown in Fig. <a href="#MOESM1" class="usa-link">2</a> in supplement 1.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12331795_415_2025_13279_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/277c/12331795/d0354fc3915e/415_2025_13279_Fig1_HTML.jpg" loading="lazy" id="MO1" height="810" width="677" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Preferred reporting items for systematic reviews and meta-analyses flow diagram</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Study characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Study</th>
<th align="left" colspan="1" rowspan="1">Author</th>
<th align="left" colspan="1" rowspan="1">Years of study</th>
<th align="left" colspan="1" rowspan="1">Intervention</th>
<th align="left" colspan="1" rowspan="1">Follow-up (months)</th>
<th align="left" colspan="1" rowspan="1">Number in group</th>
<th align="left" colspan="1" rowspan="1">Relapses (<em>n</em>)</th>
<th align="left" colspan="1" rowspan="1">Seropositive (%)</th>
<th align="left" colspan="1" rowspan="1">Relapses in seropositive (<em>n</em>)</th>
<th align="left" colspan="1" rowspan="1">Baseline EDSS (mean)</th>
<th align="left" colspan="1" rowspan="1">Age (sd)</th>
<th align="left" colspan="1" rowspan="1">Female (%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="2" colspan="1">N-MOMENTUM</td>
<td align="left" rowspan="2" colspan="1">Cree</td>
<td align="left" rowspan="2" colspan="1">2015–2018</td>
<td align="left" colspan="1" rowspan="1">Inebilizumab</td>
<td align="center" colspan="1" rowspan="1">6.5</td>
<td align="left" colspan="1" rowspan="1">174</td>
<td align="left" colspan="1" rowspan="1">21</td>
<td align="left" colspan="1" rowspan="1">161 (93)</td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">3.8</td>
<td align="left" colspan="1" rowspan="1">43 (12)</td>
<td align="left" colspan="1" rowspan="1">159 (91)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Placebo</td>
<td align="center" colspan="1" rowspan="1">6.5</td>
<td align="left" colspan="1" rowspan="1">56</td>
<td align="left" colspan="1" rowspan="1">22</td>
<td align="left" colspan="1" rowspan="1">52 (93)</td>
<td align="left" colspan="1" rowspan="1">22</td>
<td align="left" colspan="1" rowspan="1">4.2</td>
<td align="left" colspan="1" rowspan="1">43 (14)</td>
<td align="left" colspan="1" rowspan="1">50 (89)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">PREVENT</td>
<td align="left" rowspan="2" colspan="1">Pittock</td>
<td align="left" rowspan="2" colspan="1">2014–2017</td>
<td align="left" colspan="1" rowspan="1">Eculizumab</td>
<td align="center" colspan="1" rowspan="1">48.7</td>
<td align="left" colspan="1" rowspan="1">96</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">96 (100)</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">44 (13)</td>
<td align="left" colspan="1" rowspan="1">88 (92)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Placebo</td>
<td align="center" colspan="1" rowspan="1">48.7</td>
<td align="left" colspan="1" rowspan="1">47</td>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="left" colspan="1" rowspan="1">47 (100)</td>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="left" colspan="1" rowspan="1">3.9</td>
<td align="left" colspan="1" rowspan="1">45 (13)</td>
<td align="left" colspan="1" rowspan="1">42 (89)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">TANGO</td>
<td align="left" rowspan="2" colspan="1">Zhang</td>
<td align="left" rowspan="2" colspan="1">2017–2018</td>
<td align="left" colspan="1" rowspan="1">Tocilizumab</td>
<td align="center" colspan="1" rowspan="1">13.8</td>
<td align="left" colspan="1" rowspan="1">59</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">50 (85)</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">4.7</td>
<td align="left" colspan="1" rowspan="1">48 (13)</td>
<td align="left" colspan="1" rowspan="1">55 (93)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Azathioprine</td>
<td align="center" colspan="1" rowspan="1">13.8</td>
<td align="left" colspan="1" rowspan="1">59</td>
<td align="left" colspan="1" rowspan="1">28</td>
<td align="left" colspan="1" rowspan="1">53 (90)</td>
<td align="left" colspan="1" rowspan="1">25</td>
<td align="left" colspan="1" rowspan="1">4.8</td>
<td align="left" colspan="1" rowspan="1">45 (15)</td>
<td align="left" colspan="1" rowspan="1">53 (90)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">SAKURASTAR</td>
<td align="left" rowspan="2" colspan="1">Traboulsee</td>
<td align="left" rowspan="2" colspan="1">2014–2017</td>
<td align="left" colspan="1" rowspan="1">Satralizumab</td>
<td align="center" colspan="1" rowspan="1">18.0</td>
<td align="left" colspan="1" rowspan="1">63</td>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">41 (65)</td>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">3.9</td>
<td align="left" colspan="1" rowspan="1">45 (12)</td>
<td align="left" colspan="1" rowspan="1">46 (73)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Placebo</td>
<td align="center" colspan="1" rowspan="1">18.0</td>
<td align="left" colspan="1" rowspan="1">32</td>
<td align="left" colspan="1" rowspan="1">16</td>
<td align="left" colspan="1" rowspan="1">23 (72)</td>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1">3.7</td>
<td align="left" colspan="1" rowspan="1">41 (11)</td>
<td align="left" colspan="1" rowspan="1">31 (97)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">RIN-1</td>
<td align="left" rowspan="2" colspan="1">Tahara</td>
<td align="left" rowspan="2" colspan="1">2014–2017</td>
<td align="left" colspan="1" rowspan="1">Rituximab</td>
<td align="center" colspan="1" rowspan="1">16.6</td>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">19 (100)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">3.4</td>
<td align="left" colspan="1" rowspan="1">51 (13)</td>
<td align="left" colspan="1" rowspan="1">17 (89)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Placebo</td>
<td align="center" colspan="1" rowspan="1">16.6</td>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">19 (100)</td>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">50 (22)</td>
<td align="left" colspan="1" rowspan="1">19 (100)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">SAKURA-SKY</td>
<td align="left" rowspan="2" colspan="1">Yamamura</td>
<td align="left" rowspan="2" colspan="1">2014–2018</td>
<td align="left" colspan="1" rowspan="1">Satralizumab</td>
<td align="center" colspan="1" rowspan="1">24.8</td>
<td align="left" colspan="1" rowspan="1">41</td>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">27 (66)</td>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">3.8</td>
<td align="left" colspan="1" rowspan="1">41 (16)</td>
<td align="left" colspan="1" rowspan="1">37 (90)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Placebo</td>
<td align="center" colspan="1" rowspan="1">24.8</td>
<td align="left" colspan="1" rowspan="1">42</td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">28 (67)</td>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">3.6</td>
<td align="left" colspan="1" rowspan="1">43 (12)</td>
<td align="left" colspan="1" rowspan="1">40 (95)</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Azathioprine and rituximab in NMO</td>
<td align="left" rowspan="2" colspan="1">Nikoo</td>
<td align="left" rowspan="2" colspan="1">2015–2016</td>
<td align="left" colspan="1" rowspan="1">Azathioprine</td>
<td align="center" colspan="1" rowspan="1">12.0</td>
<td align="left" colspan="1" rowspan="1">46</td>
<td align="left" colspan="1" rowspan="1">1.02</td>
<td align="left" colspan="1" rowspan="1">25 (54)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">2.4</td>
<td align="left" colspan="1" rowspan="1">32 (9)</td>
<td align="left" colspan="1" rowspan="1">38 (83)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Rituximab</td>
<td align="center" colspan="1" rowspan="1">12.0</td>
<td align="left" colspan="1" rowspan="1">40</td>
<td align="left" colspan="1" rowspan="1">1.3</td>
<td align="left" colspan="1" rowspan="1">17 (43)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">34 (9)</td>
<td align="left" colspan="1" rowspan="1">34 (85)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CHAMPION-NMOSD</td>
<td align="left" colspan="1" rowspan="1">Pittock</td>
<td align="left" colspan="1" rowspan="1">2019–2022</td>
<td align="left" colspan="1" rowspan="1">Ravulizumab</td>
<td align="center" colspan="1" rowspan="1">27.7</td>
<td align="left" colspan="1" rowspan="1">58</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">58 (100)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">3.3</td>
<td align="left" colspan="1" rowspan="1">47 (14)</td>
<td align="left" colspan="1" rowspan="1">52 (90)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p18"><p><em>EDSS</em> Expanded disability status scale</p></div></div></section></section><section id="Sec9"><h3 class="pmc_sec_title">Primary outcome: time to relapse</h3>
<p id="Par14">When ranking the treatments for the primary outcome of time to relapse, ravulizumab consistently ranked first as the ideal immunotherapy (HR 0.00 (95% CrI 0.00–0.03), SUCRA 0.99). The other complement inhibitor eculizumab was ranked second (HR 0.05 (95% CrI 0.00–0.50); SUCRA 0.76). The third ranked immunotherapy was tocilizumab (HR 0.22 (95% CrI 0.03–1.80), SUCRA 0.49) followed by the B cell depleting agents rituximab (HR 0.25 (95% CrI 0.03–0.96), SUCRA 0.47) and inebilizumab (HR 0.26 (95% CrI 0.03–2.05), SUCRA 0.45), respectively (Table <a href="#Tab2" class="usa-link">2</a>, Fig. <a href="#Fig2" class="usa-link">2</a>). The forest plot of the eight interventions compared to control is shown in Fig. <a href="#Fig3" class="usa-link">3</a>. Compared to control, the HR were compatible with those previously published in the pivotal phase III randomised controlled trials with ravulizumab eculizumab and tocilizumab demonstrating the greatest reduction in time to relapse compared to control. When comparing treatments head-to-head, ravulizumab was superior to all other interventions (HR 0.0, varying 95% credibility intervals—see Table <a href="#Tab2" class="usa-link">2</a>). No other significant results were seen in indirect comparisons between treatment interventions.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Treatment rankings</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">HR (95% CrI)</th>
<th align="left" colspan="1" rowspan="1">SUCRA</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Time to relapse</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Control</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">4.54</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Eculizumab</td>
<td align="left" colspan="1" rowspan="1">0.05 (0.00, 0.50)</td>
<td align="center" colspan="1" rowspan="1">75.92</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Inebilizumab</td>
<td align="left" colspan="1" rowspan="1">0.26 (0.03, 2.05)</td>
<td align="center" colspan="1" rowspan="1">44.90</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Ravulizumab</td>
<td align="left" colspan="1" rowspan="1">0.00 (0.00, 0.03)</td>
<td align="center" colspan="1" rowspan="1">99.46</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Rituximab</td>
<td align="left" colspan="1" rowspan="1">0.25 (0.03, 0.96)</td>
<td align="center" colspan="1" rowspan="1">47.31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Satralizumab</td>
<td align="left" colspan="1" rowspan="1">0.45 (0.10, 1.96)</td>
<td align="center" colspan="1" rowspan="1">28.46</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Tocilizumab</td>
<td align="left" colspan="1" rowspan="1">0.22 (0.03, 1.80)</td>
<td align="center" colspan="1" rowspan="1">49.45</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Annualized relapse rate</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Control</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">10.39</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Eculizumab</td>
<td align="left" colspan="1" rowspan="1">0.06 (0.00, 2.36)</td>
<td align="center" colspan="1" rowspan="1">69.31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Inebilizumab</td>
<td align="left" colspan="1" rowspan="1">0.31 (0.01, 7.35)</td>
<td align="center" colspan="1" rowspan="1">44.33</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Ravulizumab</td>
<td align="left" colspan="1" rowspan="1">0.00 (0.00, 0.05)</td>
<td align="center" colspan="1" rowspan="1">98.92</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Rituximab</td>
<td align="left" colspan="1" rowspan="1">0.27 (0.01, 1.81)</td>
<td align="center" colspan="1" rowspan="1">48.40</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Satralizumab</td>
<td align="left" colspan="1" rowspan="1">0.50 (0.05, 4.77)</td>
<td align="center" colspan="1" rowspan="1">31.82</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Tocilizumab</td>
<td align="left" colspan="1" rowspan="1">0.27 (0.01, 6.75)</td>
<td align="center" colspan="1" rowspan="1">46.81</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1">Time to relapse—seropositive patients</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Control</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">6.96</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Eculizumab</td>
<td align="left" colspan="1" rowspan="1">0.06 (0.00, 3.28)</td>
<td align="center" colspan="1" rowspan="1">56.87</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Inebilizumab</td>
<td align="left" colspan="1" rowspan="1">0.26 (0.01, 11.90)</td>
<td align="center" colspan="1" rowspan="1">35.26</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Ravulizumab</td>
<td align="left" colspan="1" rowspan="1">0.00 (0.00, 0.00)</td>
<td align="center" colspan="1" rowspan="1">92.08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Rituximab</td>
<td align="left" colspan="1" rowspan="1">0.00 (0.00, 0.02)</td>
<td align="center" colspan="1" rowspan="1">90.34</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Satralizumab</td>
<td align="left" colspan="1" rowspan="1">0.31 (0.02, 4.44)</td>
<td align="center" colspan="1" rowspan="1">31.53</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">- Tocilizumab</td>
<td align="left" colspan="1" rowspan="1">0.24 (0.00, 10.79)</td>
<td align="center" colspan="1" rowspan="1">36.98</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p21"><p><em>HR</em> hazard ratio, <em>CrI</em> credibility interval, <em>SUCRA</em> surface under the cumulative ranking curve</p></div></div></section><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12331795_415_2025_13279_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/277c/12331795/3598b57f9aed/415_2025_13279_Fig2_HTML.jpg" loading="lazy" id="MO2" height="555" width="769" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Treatment rankings for time to relapse</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12331795_415_2025_13279_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/277c/12331795/0715e960cd40/415_2025_13279_Fig3_HTML.jpg" loading="lazy" id="MO3" height="478" width="672" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Forest plot of immunotherapies compared with traditional treatment</p></figcaption></figure></section><section id="Sec10"><h3 class="pmc_sec_title">Secondary outcomes: annualised relapse rate</h3>
<p id="Par15">All clinical trials were included in the secondary analysis of annualised relapse rates. The results were the same as those of the primary analysis with ravulizumab being ranked as the ideal treatment in reducing relapse rate in NMO-SD (HR 0.00 (95% CrI 0.00–0.05), SUCRA 0.99) (Table <a href="#Tab2" class="usa-link">2</a>, Fig. <a href="#MOESM1" class="usa-link">5</a> in Supplement 1) and ravulizumab being superior in decreasing annualised relapse rates compared to all other interventions.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Sub-group analysis: seropositive subgroup</h3>
<p id="Par16">The subgroup analysis of seropositive patients (<em>n</em> = 674) was derived from 7 trials as Nikoo et al. did not report the relapse rates in seropositive participants and was therefore excluded. Ravulizumab again had the highest probability of being the first ranked treatment (HR 0.00 (95% CrI 0.00–0.00), SUCRA 0.92) in increasing time to first relapse in NMO-SD. Rituximab was ranked the second therapy (HR 0.00 (95% CrI 0.00–0.02), SUCRA 0.90) followed by eculizumab (HR 0.06 (95% CrI 0.00–3.28), SUCRA 0.57). In comparisons with other treatments, ravulizumab and rituximab were superior to all other interventions (Table <a href="#Tab2" class="usa-link">2</a>, Fig. <a href="#MOESM1" class="usa-link">6</a> in Supplement 1).</p>
<p id="Par17">3.5: Safety analysis on infection rates.</p>
<p id="Par18">Our results did not identify any statistically significant differences in infection rates between the different immunotherapies (see Fig. <a href="#MOESM1" class="usa-link">7</a> in supplement 1). We were unable to compare serious infection rates due to the sparsity of this data.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Inconsistency, risk of bias</h3>
<p id="Par19">Testing for inconsistency did not reveal large differences between direct and indirect estimates. Individual trial bias demonstrated low risk for the majority of studies (Fig. <a href="#MOESM1" class="usa-link">8</a> in Supplement 1). Studies by Nikoo et al. showed some concerns owing to lack of blinding [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The CHAMPION-NMOSD trial was an externally controlled study using the placebo group from the PREVENT study [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p></section></section><section id="Sec13"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par20">In a network meta-analysis of monoclonal antibodies used for NMO-SD, ravulizumab was consistently shown to be highest ranked suggesting that it is likely to be the optimal treatment for reducing relapse risk. We use a Bayesian approach to demonstrate for the first time, the superiority of ravulizumab and treatment rankings in an analysis that includes recently approved monoclonal antibodies but also older monoclonal antibodies—rituximab and tocilizumab.</p>
<p id="Par21">Our analysis demonstrated that the two complement inhibitors ravulizumab and eculizumab had the highest probability of being the top two ranked therapies respectively. This suggests that complement inhibition may be superior to B cell depletion or IL-6 receptor blockage in relapse prevention. Complement activation, particularly via the classic pathway has been demonstrated to be a key and potentially early component of NMO-SD pathogenesis. The two complement inhibitors eculizumab &amp; ravalizumab block the cleavage of C5 to C5a and C5b thereby preventing damage mediated by C5a (potent anaphylatoxin) and the terminal pathway leading to membrane attack complex formation [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Furthermore, the complement system can bridge the innate and adaptive immune systems by modulating activation of both B and T cells [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. We postulate that the prevention of these multiple pathways that cover direct astrocyte destruction and the lesser role of reducing B/T cell stimulation may explain the superior ranking of the complement inhibitors.</p>
<p id="Par22">It is important to note the CHAMPION-NMO-SD trial of ravulizumab did not use a placebo arm and used the placebo arm of the PREVENT trial [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. As a result of this, in the analysis we incorporated ravulizumab as one arm of a multi-arm study with a common placebo arm. Our findings are in keeping with the only network meta-analysis by Clardy et al. that has incorporated ravulizumab which showed ravulizumab to be comparable to eculizumab and superior to inebilizumab and satralizumab in relapse prevention in NMO-SD [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<p id="Par23">Tocilizumab, an IL-6 receptor antagonist was the third ranked treatment whilst its IL-6 counterpart, satralizumab was the 6th ranked treatment. Tocilizumab was not studied in the most recent NMA of NMO-SD by Clardy et al. and previous NMA were published before ravulizumab was published [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Tocilizumab was studied in a randomised controlled trial against azathioprine (TANGO) of highly relapsing NMO-SD and contained 90% seropositive patients decreasing time to first relapse by 76% (HR 0.24) [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. The inclusion criteria were very similar to the more recent clinical trials such as N-MOMENTUM, PREVENT with a pre-specified level of minimum baseline relapse activity prior to randomisation [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. An active comparator azathioprine was used here and those commencing azathioprine at randomisation were given concomitant immunosuppressive therapy until week 24 making any potential treatment effect of tociliuzmab potentially greater given the majority of other studies used a placebo comparator. Its IL-6 blocking counterpart, satralizumab was the 6th ranked therapy with two studies of similar inclusion criteria showing similar results but minimal effect in those with seronegative NMO. However, the proportion of seronegative participants in SAKURA-STAR and SAKURA-Sky were 65–72% across both studies compared to 90% in TANGO [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. IL-6 clearly plays a significant role in NMO-SD as evidenced by increased IL-6 in CSF, serum and increases during times of disease activity; and positive clinical trials of anti-IL-6 receptor blockers but it is possible that IL-6 activity in seronegative NMO-SD may differ compared to seropositive disease.</p>
<p id="Par24">The B-cell depleting agents, rituximab (anti CD-20) and inebilizumab (anti CD19) were the 4th and 5th ranked treatments respectively. Rituximab is an older immunotherapy and has been used off label in many countries for NMO-SD. It has been studied in two randomised controlled trials—against placebo (RIN-1) and azathioprine [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Neither included participants on the basis of relapse activity prior to randomisation but in the RIN-1 study, 58–63% had a relapse in preceding 2 years with an ARR 1.4 in rituximab arm v 0.7 in placebo. The study using azathioprine as an active comparator used ARR as the primary endpoint and included a higher proportion of seronegative participants in each arm (42–54%) [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. However despite these differences, the results between the two B-cell depleting agents was similar. This is also similar to a previous Bayesian NMA completed by Yin et al. who showed that rituximab was the first ranked choice by SUCRA in reducing ARR [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. However, this study included RCT, prospective and retrospective studies and the primary outcome analysis of ARR did not include inebilizumab [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Our results provide indirect evidence that B cell depletion using either rituximab or inebilizumab are also effective options in relapse prevention in NMO-SD.</p>
<p id="Par25">In a post-hoc analysis of infection rates, we were unable to detect differences between treatment interventions. The previous study by Clardy et al. did not examine safety outcomes [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. There are several limitations when interpreting our results. First, there were differences in the reporting of infection rates. For example: TANGO, CHAMPION, PREVENT all reported infections that occurred in &gt; 10% participants, RIN-1 study reported infections occurring in &gt; 20% patients, whilst the remainder did not set minimum frequency to report infections (except N-MOMENTUM study of inebilizumab where infections ≥ 2.5% were reported) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Second, due to relative sparsity of data we were unable to analyse whether there were differences in serious infection rates between the different treatments and, therefore, no conclusions can be drawn about this.</p>
<section id="Sec14"><h3 class="pmc_sec_title">Strengths and limitations</h3>
<p id="Par26">The strengths of the study are the use of Bayesian network meta-analyses that enable indirect comparisons to enable treatment ranking that otherwise is not possible. We expand on previous literature and incorporate all available monoclonal antibodies that have previously not been present in previous NMA as they were published prior to the availability of ravulizumab or not included in the analysis (rituximab, tocilizumab) [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. In particular, our incorporation of rituximab, which has widespread off-label usage, is important to understand its treatment ranking in the current landscape as newer monoclonal antibodies such as ravalizumab, eculizumab and satrilizumab are not yet approved for use in a number of countries. There are several limitations to the study—Bayesian network meta-analysis uses indirect comparisons and need to be interpreted as such and is not a substitute for randomised controlled trials. However, in the current era Bayesian NMA presents an approach for treatment comparison that would otherwise not occur due to feasibility and cost of repeated head-to-head randomised controlled trials. Another limitation of the study is smaller number of trials per comparison and the relatively small sample sizes in the individual arms of the respective trials. Satralizumab and rituximab each had two randomised control trials respectively; the rest of the treatment interventions had only 1 randomised clinical trial. However, there was overlap with the mechanisms of the treatment agents with treatments grouped into being B-cell depleting (rituximab, inebilizumab), anti-IL-6 (satralizumab, tocilizumab) and complement inhibition (eculizumab, ravalizumab). The highest sample size was for the inebilizumab treatment group with 174 with rest being below 100 and the lowest being 19 in the RIN-1 study of rituximab. However, each trial recruited to target with all except 1 having the requisite number of adjudicated events (relapses) to be adequately powered. The smaller sample sizes in the clinical trials are an inherent reflection of the relatively low prevalence/incidence of this disease and low sample sizes needed given the natural history of the disease and the severity of the relapses. The subgroup analysis of seropositive groups demonstrated a similar result with ravulizumab but rituximab was shown to be second ranked treatment. This was an effect of not including the Nikoo study which did not state the relapse rate in those that were seropositive and, therefore, favourably weighted rituximab. Furthermore, the only seropositive group that reported relapses did not experience a relapse and we are, therefore, unable to conclude whether rituximab is similar in efficacy to ravulizumab. Differences in relapse inclusion criteria are unlikely to be of significance—the studies that did not mandate minimum relapse activity prior to randomisation had baseline ARR that was similar to those that did incorporate relapse activity prior to randomisation. Last, combining placebo and azathioprine arms into a single ‘control’ group introduces heterogeneity, but allowing for separation of traditional treatments introduces added network complexity and artefact and was considered a reasonable compromise.</p>
<p id="Par27">In summary, the two complement inhibitors, ravulizumab and eculizumab were shown to be the highest ranked treatments in relapse prevention in NMO-SD. Our findings inform treatment decision making from an efficacy perspective and need to be balanced against safety when deciding on an appropriate immunosuppressive strategy in NMO-SD.</p></section></section><section id="Sec15"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12331795/bin/415_2025_13279_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (PDF 281 KB)</a><sup> (281.4KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>NAJ is supported by the Monash University School of Clinical Sciences Early Career Practitioner fellowship.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>NAJ, TP were involved in hypothesis generation, aims, data acquisition, analysis, drafting of manuscript. AL was involved in data analysis, drafting and revision of the manuscript. SR, LZ, JC, JB and VC were involved in data acquisition and revision of the manuscript. HM was involved in manuscript revision and editing.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open Access funding enabled and organized by CAUL and its Member Institutions.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>These data are available from the publications related to each clinical trials. Data can be accessed by researchers whose proposed use of the data has been approved. The can be made available with investigator support.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Conflicts of interest</h3>
<p id="Par28">AL, LZ, SR, JC, JB, VC, HM, TP have no conflicts of interest to disclose. NAJ is a principal investigator on commercial MS trials sponsored by Roche, Novartis and Biogen. He has received speakers honoraria and consultancy fees from Merck. He has received travel congress and sponsorship; and consultancy fees from Novartis.</p></section></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Wingerchuk DM, Lucchinetti CF (2022) Neuromyelitis optica spectrum disorder. N Engl J Med 387(7):631–639. 10.1056/NEJMra1904655
</cite> [<a href="https://doi.org/10.1056/NEJMra1904655" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36070711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wingerchuk%20DM,%20Lucchinetti%20CF%20(2022)%20Neuromyelitis%20optica%20spectrum%20disorder.%20N%20Engl%20J%20Med%20387(7):631%E2%80%93639.%2010.1056/NEJMra1904655" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189. 10.1212/wnl.0000000000001729
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000001729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4515040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26092914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wingerchuk%20DM,%20Banwell%20B,%20Bennett%20JL%20et%20al%20(2015)%20International%20consensus%20diagnostic%20criteria%20for%20neuromyelitis%20optica%20spectrum%20disorders.%20Neurology%2085(2):177%E2%80%93189.%2010.1212/wnl.0000000000001729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Nikoo Z, Badihian S, Shaygannejad V, Asgari N, Ashtari F (2017) Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial. J Neurol 264(9):2003–2009. 10.1007/s00415-017-8590-0
</cite> [<a href="https://doi.org/10.1007/s00415-017-8590-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28831548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nikoo%20Z,%20Badihian%20S,%20Shaygannejad%20V,%20Asgari%20N,%20Ashtari%20F%20(2017)%20Comparison%20of%20the%20efficacy%20of%20azathioprine%20and%20rituximab%20in%20neuromyelitis%20optica%20spectrum%20disorder:%20a%20randomized%20clinical%20trial.%20J%20Neurol%20264(9):2003%E2%80%932009.%2010.1007/s00415-017-8590-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Tahara M, Oeda T, Okada K et al (2020) Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 19(4):298–306. 10.1016/S1474-4422(20)30066-1
</cite> [<a href="https://doi.org/10.1016/S1474-4422(20)30066-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32199095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tahara%20M,%20Oeda%20T,%20Okada%20K%20et%20al%20(2020)%20Safety%20and%20efficacy%20of%20rituximab%20in%20neuromyelitis%20optica%20spectrum%20disorders%20(RIN-1%20study):%20a%20multicentre,%20randomised,%20double-blind,%20placebo-controlled%20trial.%20Lancet%20Neurol%2019(4):298%E2%80%93306.%2010.1016/S1474-4422(20)30066-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Cree BAC, Bennett JL, Kim HJ et al (2019) Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. The Lancet 394(10206):1352–1363. 10.1016/S0140-6736(19)31817-3</cite> [<a href="https://doi.org/10.1016/S0140-6736(19)31817-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31495497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cree%20BAC,%20Bennett%20JL,%20Kim%20HJ%20et%20al%20(2019)%20Inebilizumab%20for%20the%20treatment%20of%20neuromyelitis%20optica%20spectrum%20disorder%20(N-MOmentum):%20a%20double-blind,%20randomised%20placebo-controlled%20phase%202/3%20trial.%20The%20Lancet%20394(10206):1352%E2%80%931363.%2010.1016/S0140-6736(19)31817-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Zhang C, Zhang M, Qiu W et al (2020) Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial. Lancet Neurol 19(5):391–401. 10.1016/s1474-4422(20)30070-3
</cite> [<a href="https://doi.org/10.1016/S1474-4422(20)30070-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7935423/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32333897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20C,%20Zhang%20M,%20Qiu%20W%20et%20al%20(2020)%20Safety%20and%20efficacy%20of%20tocilizumab%20versus%20azathioprine%20in%20highly%20relapsing%20neuromyelitis%20optica%20spectrum%20disorder%20(TANGO):%20an%20open-label,%20multicentre,%20randomised,%20phase%202%20trial.%20Lancet%20Neurol%2019(5):391%E2%80%93401.%2010.1016/s1474-4422(20)30070-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Traboulsee A, Greenberg BM, Bennett JL et al (2020) Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. Lancet Neurol 19(5):402–412. 10.1016/s1474-4422(20)30078-8
</cite> [<a href="https://doi.org/10.1016/S1474-4422(20)30078-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7935419/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32333898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Traboulsee%20A,%20Greenberg%20BM,%20Bennett%20JL%20et%20al%20(2020)%20Safety%20and%20efficacy%20of%20satralizumab%20monotherapy%20in%20neuromyelitis%20optica%20spectrum%20disorder:%20a%20randomised,%20double-blind,%20multicentre,%20placebo-controlled%20phase%203%20trial.%20Lancet%20Neurol%2019(5):402%E2%80%93412.%2010.1016/s1474-4422(20)30078-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Yamamura T, Kleiter I, Fujihara K et al (2019) Trial of satralizumab in neuromyelitis optica spectrum disorder. New Engl J Med 381(22):2114–2124. 10.1056/NEJMoa1901747
</cite> [<a href="https://doi.org/10.1056/NEJMoa1901747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31774956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamamura%20T,%20Kleiter%20I,%20Fujihara%20K%20et%20al%20(2019)%20Trial%20of%20satralizumab%20in%20neuromyelitis%20optica%20spectrum%20disorder.%20New%20Engl%20J%20Med%20381(22):2114%E2%80%932124.%2010.1056/NEJMoa1901747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Pittock SJ, Barnett M, Bennett JL et al (2023) Ravulizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder. Ann Neurol 93(6):1053–1068. 10.1002/ana.26626
</cite> [<a href="https://doi.org/10.1002/ana.26626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36866852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pittock%20SJ,%20Barnett%20M,%20Bennett%20JL%20et%20al%20(2023)%20Ravulizumab%20in%20aquaporin-4%E2%80%93positive%20neuromyelitis%20optica%20spectrum%20disorder.%20Ann%20Neurol%2093(6):1053%E2%80%931068.%2010.1002/ana.26626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Pittock SJ, Berthele A, Fujihara K et al (2019) Eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder. New Engl J Med 381(7):614–625. 10.1056/NEJMoa1900866
</cite> [<a href="https://doi.org/10.1056/NEJMoa1900866" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31050279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pittock%20SJ,%20Berthele%20A,%20Fujihara%20K%20et%20al%20(2019)%20Eculizumab%20in%20aquaporin-4%E2%80%93positive%20neuromyelitis%20optica%20spectrum%20disorder.%20New%20Engl%20J%20Med%20381(7):614%E2%80%93625.%2010.1056/NEJMoa1900866" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Clardy SL, Pittock SJ, Aktas O et al (2024) Network meta-analysis of ravulizumab and alternative interventions for the treatment of neuromyelitis optica spectrum disorder. Neurol Ther 13(3):535–549. 10.1007/s40120-024-00597-7
</cite> [<a href="https://doi.org/10.1007/s40120-024-00597-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11136926/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38722571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clardy%20SL,%20Pittock%20SJ,%20Aktas%20O%20et%20al%20(2024)%20Network%20meta-analysis%20of%20ravulizumab%20and%20alternative%20interventions%20for%20the%20treatment%20of%20neuromyelitis%20optica%20spectrum%20disorder.%20Neurol%20Ther%2013(3):535%E2%80%93549.%2010.1007/s40120-024-00597-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Aungsumart S, Youngkong S, Dejthevaporn C et al (2023) Efficacy and safety of monoclonal antibody therapy in patients with neuromyelitis optica spectrum disorder: a systematic review and network meta-analysis. Front Neurol 14:1166490. 10.3389/fneur.2023.1166490
</cite> [<a href="https://doi.org/10.3389/fneur.2023.1166490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10110910/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37082442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aungsumart%20S,%20Youngkong%20S,%20Dejthevaporn%20C%20et%20al%20(2023)%20Efficacy%20and%20safety%20of%20monoclonal%20antibody%20therapy%20in%20patients%20with%20neuromyelitis%20optica%20spectrum%20disorder:%20a%20systematic%20review%20and%20network%20meta-analysis.%20Front%20Neurol%2014:1166490.%2010.3389/fneur.2023.1166490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Yin Z, Qiu Y, Duan A et al (2023) Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis. J Neurol 270(6):2950–2963. 10.1007/s00415-023-11641-1
</cite> [<a href="https://doi.org/10.1007/s00415-023-11641-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10188410/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36884069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20Z,%20Qiu%20Y,%20Duan%20A%20et%20al%20(2023)%20Different%20monoclonal%20antibodies%20and%20immunosuppressants%20administration%20in%20patients%20with%20neuromyelitis%20optica%20spectrum%20disorder:%20a%20Bayesian%20network%20meta-analysis.%20J%20Neurol%20270(6):2950%E2%80%932963.%2010.1007/s00415-023-11641-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Xu X, Xie L, Wei L et al (2022) Efficacy and safety of monoclonal antibodies in neuromyelitis optica spectrum disorders: a survival meta-analysis of randomized controlled trials. Adv Ophthalmol Pract Res 2(3):100064. 10.1016/j.aopr.2022.100064
</cite> [<a href="https://doi.org/10.1016/j.aopr.2022.100064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10577852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37846287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20X,%20Xie%20L,%20Wei%20L%20et%20al%20(2022)%20Efficacy%20and%20safety%20of%20monoclonal%20antibodies%20in%20neuromyelitis%20optica%20spectrum%20disorders:%20a%20survival%20meta-analysis%20of%20randomized%20controlled%20trials.%20Adv%20Ophthalmol%20Pract%20Res%202(3):100064.%2010.1016/j.aopr.2022.100064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Hutton B, Salanti G, Caldwell DM et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784. 10.7326/m14-2385
</cite> [<a href="https://doi.org/10.7326/M14-2385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26030634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hutton%20B,%20Salanti%20G,%20Caldwell%20DM%20et%20al%20(2015)%20The%20PRISMA%20extension%20statement%20for%20reporting%20of%20systematic%20reviews%20incorporating%20network%20meta-analyses%20of%20health%20care%20interventions:%20checklist%20and%20explanations.%20Ann%20Intern%20Med%20162(11):777%E2%80%93784.%2010.7326/m14-2385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Covidence systematic review software. Veritas Health Innovation. Accessed Sep 2024.</cite>
</li>
<li id="CR17">
<span class="label">17.</span><cite>Higgins JP, Page MJ, Elbers RG, Sterne JA (2019) Assessing risk of bias in a randomized trial. Wiley, Hoboken (NJ), pp 205–228</cite> [<a href="https://scholar.google.com/scholar_lookup?Higgins%20JP,%20Page%20MJ,%20Elbers%20RG,%20Sterne%20JA%20(2019)%20Assessing%20risk%20of%20bias%20in%20a%20randomized%20trial.%20Wiley,%20Hoboken%20(NJ),%20pp%20205%E2%80%93228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64(2):163–171. 10.1016/j.jclinepi.2010.03.016
</cite> [<a href="https://doi.org/10.1016/j.jclinepi.2010.03.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20688472/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Salanti%20G,%20Ades%20AE,%20Ioannidis%20JP%20(2011)%20Graphical%20methods%20and%20numerical%20summaries%20for%20presenting%20results%20from%20multiple-treatment%20meta-analysis:%20an%20overview%20and%20tutorial.%20J%20Clin%20Epidemiol%2064(2):163%E2%80%93171.%2010.1016/j.jclinepi.2010.03.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Béliveau A, Boyne DJ, Slater J, Brenner D, Arora P (2019) BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network meta-analyses. BMC Med Res Methodol 19(1):196. 10.1186/s12874-019-0829-2
</cite> [<a href="https://doi.org/10.1186/s12874-019-0829-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6805536/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31640567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?B%C3%A9liveau%20A,%20Boyne%20DJ,%20Slater%20J,%20Brenner%20D,%20Arora%20P%20(2019)%20BUGSnet:%20an%20R%20package%20to%20facilitate%20the%20conduct%20and%20reporting%20of%20Bayesian%20network%20meta-analyses.%20BMC%20Med%20Res%20Methodol%2019(1):196.%2010.1186/s12874-019-0829-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Efthimiou O, Debray TP, van Valkenhoef G et al (2016) GetReal in network meta-analysis: a review of the methodology. Res Synth Methods 7(3):236–263. 10.1002/jrsm.1195
</cite> [<a href="https://doi.org/10.1002/jrsm.1195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26754852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Efthimiou%20O,%20Debray%20TP,%20van%20Valkenhoef%20G%20et%20al%20(2016)%20GetReal%20in%20network%20meta-analysis:%20a%20review%20of%20the%20methodology.%20Res%20Synth%20Methods%207(3):236%E2%80%93263.%2010.1002/jrsm.1195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Dias S, Sutton AJ, Caldwell DM, Lu G, Ades A. NICE DSU Technical support document 4: inconsistency in networks of evidence based on randomised controlled trials. <a href="https://www.sheffield.ac.uk/sites/default/files/2022-02/TSD4-Inconsistency.final_.15April2014.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sheffield.ac.uk/sites/default/files/2022-02/TSD4-Inconsistency.final_.15April2014.pdf</a>. Accessed 1 Oct 2024</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27466656/" class="usa-link">PubMed</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Asavapanumas N, Tradtrantip L, Verkman AS (2021) Targeting the complement system in neuromyelitis optica spectrum disorder. Expert Opin Biol Ther 21(8):1073–1086. 10.1080/14712598.2021.1884223
</cite> [<a href="https://doi.org/10.1080/14712598.2021.1884223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8316261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33513036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Asavapanumas%20N,%20Tradtrantip%20L,%20Verkman%20AS%20(2021)%20Targeting%20the%20complement%20system%20in%20neuromyelitis%20optica%20spectrum%20disorder.%20Expert%20Opin%20Biol%20Ther%2021(8):1073%E2%80%931086.%2010.1080/14712598.2021.1884223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Varela JC, Tomlinson S (2015) Complement: an overview for the clinician. Hematol Oncol Clin North Am 29(3):409–427. 10.1016/j.hoc.2015.02.001
</cite> [<a href="https://doi.org/10.1016/j.hoc.2015.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4456616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26043382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Varela%20JC,%20Tomlinson%20S%20(2015)%20Complement:%20an%20overview%20for%20the%20clinician.%20Hematol%20Oncol%20Clin%20North%20Am%2029(3):409%E2%80%93427.%2010.1016/j.hoc.2015.02.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12331795/bin/415_2025_13279_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (PDF 281 KB)</a><sup> (281.4KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>These data are available from the publications related to each clinical trials. Data can be accessed by researchers whose proposed use of the data has been approved. The can be made available with investigator support.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Neurology are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s00415-025-13279-7"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/415_2025_Article_13279.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (981.5 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12331795/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12331795/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12331795%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331795/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12331795/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12331795/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40775082/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12331795/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40775082/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12331795/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12331795/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="HX3qIzfUWw31CdRNJ2lq4hyPxrKwhQIaPjnfsJM3sdhXn8vcMiwszBcoFSIxCnUK">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
